Form 4 for CRM Salesforce
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-22 · accession 0001127602-23-030451 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-26 | 2023-12-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $126.26 | +9,210 | 7,464 | New | +$1.16M |
| DM | 2023-12-26 | 2023-12-22+ | CRM | Millham Brian | Pres, COO | S - Sale+OE | $266.64 | -7,548 | 1,662 | -82% | -$2.01M |
| DM | 2023-12-26 | 2023-12-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -9,210 | 8,173 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-22 | M | A | 2,017 | $215.17 | 5,357 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-26 | S | D | 821 | $265.39 | 2,519 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-22 | S | D | 5,870 | $267.00 | 3,340 | D | — | — | |
| 4 | Common | Common Stock | 2023-12-22 | M | A | 1,746 | $154.14 | 9,210 | D | — | — | |
| 5 | Common | Common Stock | 2023-12-22 | M | A | 1,706 | $0.00 | 3,340 | D | — | — | |
| 6 | Common | Common Stock | 2023-12-22 | M | A | 1,634 | $0.00 | 1,634 | D | — | — | |
| 7 | Common | Common Stock | 2023-12-22 | M | A | 2,107 | $218.21 | 7,464 | D | — | — | |
| 8 | Common | Common Stock | 2023-12-26 | S | D | 857 | $265.39 | 1,662 | D | — | — | |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-12-22 | M | D | 1,746 | $0.00 | 6,982 | D | $154.14 · 2021-04-22 to 2027-04-22 | 1,746 Common Stock | (F8) Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 10 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-12-22 | M | D | 2,107 | $0.00 | 56,880 | D | $218.21 · 2023-03-22 to 2029-03-22 | 2,107 Common Stock | (F7) Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 11 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-12-22 | M | D | 2,017 | $0.00 | 30,268 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,017 Common Stock | (F6) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 12 | Derivative | Restricted Stock Units | 2023-12-22 | M | D | 1,706 | $0.00 | 15,359 | D | $0.00 · 2023-03-22 to 2026-03-22 | 1,706 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F5) These restricted stock units vest as to 25% of the original grant on March 22, 2023 and vest as to 1/16 of the original grant quarterly thereafter. |
| 13 | Derivative | Restricted Stock Units | 2023-12-22 | M | D | 1,634 | $0.00 | 8,173 | D | $0.00 · 2022-03-22 to 2025-03-22 | 1,634 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F4) These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter. |